Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)

NCT01426204 is registered in ClinicalTrials.gov with Closter Pharma as lead sponsor.

NCT NCT01426204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01426204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)
Lead sponsor
Closter Pharma
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2011
Completion date
August 31, 2013
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c